DIN 02326442 — TYKERB 250 MG
TYKERB is a tablet of Lapatinib marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Lapatinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02326442
- Brand name
- TYKERB
- Active ingredient
- Lapatinib
- Strength
- 250 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Dual EGFR/HER2 tyrosine kinase inhibitor (antineoplastic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.